비교리스트

 카트 문의
시장보고서
상품코드
1579661

세계의 정맥 스텐트 시장

Venous Stents
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 193 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

정맥 스텐트 세계 시장은 2030년까지 21억 달러에 달할 것으로 예상됩니다

2023년 12억 달러로 추정되는 정맥 스텐트 세계 시장은 2030년에는 21억 달러에 달할 것으로 예상되며, 2023-2030년간 8.4%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 이 보고서에서 분석한 부문 중 하나인 장골정맥 스텐트 기술은 8.3%의 연평균 복합 성장률(CAGR)을 기록하여 분석 기간 종료 시점에 14억 달러에 도달할 것으로 예상됩니다. 벽 스텐트 기술 부문의 성장률은 분석 기간 동안 CAGR 8.5%로 추정됩니다.

미국 시장은 3억 1,900만 달러로 추정, 중국은 CAGR 11.2%로 성장 전망

미국 정맥 스텐트 시장은 2023년 3억 1,900만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023-2030년간 11.2%의 연평균 복합 성장률(CAGR)을 나타내고, 2030년까지 4억 7,450만 달러 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 분석 기간 동안 각각 5.5%와 6.7%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 약 6.5%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

세계 정맥 스텐트 시장 - 주요 동향 및 시장 성장 촉진요인 살펴보기

정맥 스텐트가 혈관 질환 관리에서 점점 더 중요해지는 이유는 무엇일까?

정맥 스텐트는 정맥 폐색, 심부정맥 혈전증(DVT) 및 기타 혈관 질환을 앓고 있는 환자들에게 최소 침습적 솔루션을 제공함으로써 만성 정맥 질환 관리에 중요한 도구로 등장했습니다. 그렇다면 왜 이러한 기기가 현대 혈관 치료에 필수적인 것일까? 정맥 스텐트는 적절한 혈류를 회복하고 정맥의 허탈과 막힘을 방지하기 위해 정맥에 삽입되는 작은 메쉬 모양의 작은 금속 튜브입니다. 이 스텐트는 정맥 부전(정맥이 하지에서 심장으로 혈액을 효과적으로 되돌려 보내지 못해 통증, 부종, 정맥류와 같은 증상을 유발하는 상태)을 해결하기 위해 특별히 고안된 것입니다. 고압의 혈류를 다루는 동맥에 사용되는 동맥 스텐트와 달리 정맥 스텐트는 혈압이 낮고 구조적 특성이 다른 정맥에 최적화되어 있습니다. 그 디자인은 유연성과 혈관벽에 대한 적합성을 보장하기 때문에 정맥의 개통성을 유지하고 정맥 폐색으로 인한 증상을 완화하는 데 매우 효과적입니다.

전 세계적으로 수백만 명이 앓고 있으며, 방치할 경우 심각한 합병증을 유발할 수 있는 만성 정맥 질환의 유병률 증가가 정맥 스텐트 수요를 주도하고 있습니다. 압박 요법이나 항응고제와 같은 기존 치료법으로는 진행성 정맥 폐쇄를 관리하기에 충분하지 않은 경우가 많아 스텐트 삽입술이 선호되는 치료법이 되고 있습니다. 정맥 스텐트는 좁아지거나 막힌 정맥을 물리적으로 개통시켜 혈류를 개선하고 하지 궤양이나 혈전증 재발과 같은 합병증 위험을 줄여 장기적인 해결책을 제시합니다. 정맥 스텐트는 특히 혈전 후 증후군(PTS), 장골정맥 압박 증후군(May-Thurner 증후군) 등의 치료에 많이 사용되며, 스텐트 삽입술은 환자의 예후와 삶의 질을 크게 개선하는 것으로 나타났습니다. 정맥 질환과 스텐트 시술의 이점에 대한 인식이 높아짐에 따라, 의료진은 복잡한 정맥 병변에 대한 첫 번째 선택으로 정맥 스텐트를 선택하게 되었습니다.

기술 혁신은 정맥 스텐트의 효과를 어떻게 향상시키고 있는가?

정맥 스텐트 시장은 이러한 장치의 안전성, 유효성 및 내구성을 향상시키는 중요한 기술 발전을 목격했습니다. 그렇다면 이러한 발전의 원동력이 되고 있는 주요 기술 혁신은 무엇일까? 가장 주목할 만한 발전 중 하나는 정맥 특유의 해부학적, 생리적 문제를 해결하기 위한 정맥 전용 스텐트의 개발입니다. 동맥용으로 설계된 기존 스텐트는 정맥의 생역학적 특성이 다르기 때문에 정맥 환경에서 사용했을 때 최적의 결과를 얻지 못하는 경우가 많았습니다. 이에 따라 각 제조업체들은 유연성, 직경 방향의 힘, 꼬임 및 압박에 대한 저항성 등의 특징을 갖춘 정맥 전용 스텐트를 출시하고 있습니다. 이러한 스텐트는 굴곡진 혈관이나 고도로 구부러진 혈관에서도 정맥의 해부학적 구조에 맞게 설계되어 장기적인 개통성을 보장하고 이동 및 파열의 위험을 최소화합니다. 또한, 니티놀과 코발트 크롬 합금을 스텐트 구조에 사용하여 강도와 탄성을 향상시켜 큰 직경의 정맥과 고압축 부위에 적합하도록 설계되었습니다.

또 다른 중요한 혁신은 약물 용출성 스텐트의 도입입니다. 이 스텐트는 조직의 과도한 증식을 방지하고 스텐트 내 재협착의 위험을 감소시키는 약리학적인 약물로 코팅되어 있습니다. 동맥 스텐트에서 이미 성공을 거둔 이 기술은 재협착의 위험이 중요한 문제인 정맥 스텐트에서도 유망한 기술로 평가받고 있습니다. 약물 용출형 스텐트는 시간이 지남에 따라 항증식제를 방출하여 스텐트 내 흉터 조직의 증식을 억제하여 내강의 개통성을 유지합니다. 또한 혈관 내 초음파(IVUS) 및 디지털 견인 혈관 조영술(DSA)과 같은 영상 기술의 발전으로 스텐트 배치의 정확도가 향상되어 정맥의 형태를보다 정확하게 평가할 수있어 스텐트를 최적의 위치에 배치 할 수있게되었습니다. 이러한 기술의 통합은 정맥 스텐트의 안전성과 유효성을 향상시켰을 뿐만 아니라 다단계 정맥 폐색 및 재발성 DVT와 같은 더 복잡한 사례에 대한 사용을 확대했습니다. 그 결과, 다양한 정맥 질환에 대한 정맥 스텐트의 효능이 크게 향상되어 임상 현장에서의 채택이 증가하고 있습니다.

혈관 치료에서 정맥 스텐트의 채택을 촉진하는 시장 동향은 무엇인가?

혈관 치료에서 정맥 스텐트의 채택은 환자와 의료 서비스 제공업체 모두의 진화하는 요구를 반영하는 몇 가지 새로운 시장 트렌드를 보이고 있습니다. 가장 눈에 띄는 트렌드 중 하나는 최소침습적 시술에 대한 관심이 높아지고 있다는 점입니다. 환자와 의료진이 회복 시간 단축, 합병증 발생률 감소, 입원 기간 단축을 우선순위로 삼으면서 정맥 질환에 대한 혈관 내 치료로 전환하는 추세가 두드러지고 있습니다. 정맥 스텐트 삽입술은 기존의 개복 수술에 비해 외상이 적어 만성 정맥 부전 및 정맥 폐색 관리에 선호되는 최소 침습적 치료법으로 각광받고 있습니다. 이러한 추세는 특히 선진국에서 두드러지게 나타나고 있으며, 높은 수준의 의료 인프라와 환자들의 높은 인식 수준이 최소침습적 시술의 광범위한 채택을 뒷받침하고 있습니다. 또한, 외래 시술로의 전환도 정맥 스텐트에 대한 수요를 촉진하고 있습니다. 정맥 스텐트는 대부분 당일 시술이 가능하기 때문에 환자의 일상 생활에 미치는 지장을 최소화할 수 있기 때문입니다.

정맥 스텐트 채택을 촉진하는 또 다른 중요한 추세는 만성 정맥 질환이 공중 보건의 큰 문제라는 인식이 높아지고 있다는 점입니다. 전 세계 인구의 고령화, 비만, 좌식 생활습관, 장시간 부동과 같은 위험 요인 증가로 인해 정맥 질환의 유병률은 증가 추세에 있습니다. 이에 따라 조기 진단과 조기 개입의 중요성에 대한 의료진과 환자들의 인식이 높아지고 있습니다. 이에 따라 정맥 폐색이 정맥 궤양이나 폐색전증과 같은 심각한 합병증으로 발전하기 전에 선별 및 치료하는 것에 대한 중요성이 강조되고 있습니다. 정맥 스텐트의 채택은 정맥 질환 관리에서 스텐트 삽입술의 역할을 강조하는 임상 가이드라인과 합의문 발표로 인해 더욱 가속화되고 있습니다. 주요 혈관학회에서 발행한 이 가이드라인은 환자 선택, 시술 및 시술 후 관리에 대한 명확한 지침을 제시하여 임상에서 정맥 스텐트의 보급과 표준화를 촉진하고 있습니다. 이러한 추세는 정맥 질환을 보다 적극적이고 효과적으로 관리하기 위한 광범위한 변화를 반영하며, 정맥 스텐트를 현대 혈관 치료 전략의 핵심으로 자리 매김하고 있습니다.

정맥 스텐트 세계 시장 성장을 가속하는 요인은 무엇인가?

정맥 스텐트 세계 시장 성장은 스텐트 기술의 발전, 정맥 질환의 유병률 증가, 최소 침습 수술에 대한 수요 증가 등 여러 가지 요인에 의해 주도되고 있습니다. 주요 성장 요인 중 하나는 PTS 및 장골정맥 압박과 같은 복잡한 정맥 병변의 치료에 정맥 스텐트 사용이 확대되고 있다는 점입니다. 이러한 질환에 대한 인식이 높아지고 진단 능력이 향상됨에 따라 스텐트 시술이 필요한 환자가 증가하면서 정맥 스텐트에 대한 수요가 증가하고 있습니다. 정맥의 해부학적 문제를 해결하기 위해 특별히 고안된 정맥 스텐트 전용 기기가 기존 스텐트에 비해 우수한 임상적 결과를 제공한다는 점도 시장 성장에 기여하고 있습니다. 유연성, 반경 방향 강도 및 압박에 대한 저항성이 강화된 차세대 스텐트의 개발로 인해 정맥 스텐트 시술의 혜택을 받을 수 있는 환자의 범위가 더욱 확대되어 1차 및 재발성 정맥 폐색 환자 모두에 적용이 확대되고 있습니다.

또 다른 주요 성장 요인은 의료기기 제조업체의 연구개발 투자 증가입니다. 경쟁이 치열해짐에 따라 제조업체들은 환자와 임상의의 미충족 수요를 충족시키기 위해 개선된 디자인과 첨단 코팅이 적용된 혁신적인 정맥 스텐트 개발에 집중하고 있습니다. 새로운 스텐트의 장기적인 안전성과 유효성을 입증하는 임상시험과 연구는 의료진의 신뢰도를 높이고, 임상에서 스텐트의 보급을 촉진하는 데 도움이 되고 있습니다. 또한, 만성 정맥질환, 특히 노년층에서 만성 정맥질환의 부담이 증가함에 따라 보다 효과적인 치료 옵션에 대한 요구가 증가하고 있습니다. 전 세계 인구의 고령화로 인해 정맥 질환의 유병률이 증가할 것으로 예상됨에 따라 정맥 스텐트에 대한 수요는 더욱 증가할 것으로 예상됩니다. 보험 상환 정책의 지지와 스텐트 삽입술의 임상적 이점에 대한 인식이 높아짐에 따라 세계 정맥 스텐트 시장은 기술 혁신, 임상적 채택, 인구 동향의 역동적인 상호 작용으로 인해 지속적인 성장이 예상됩니다.

조사 대상 기업 예시(주목받는 43개 기업)

  • BARD, A Becton, Dickinson Company
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Gore Medical
  • Jotec GmbH
  • OptiMed Medizinische Instrumente GmbH

    목차

    제1장 조사 방법

    제2장 주요 요약

    • 시장 개요
    • 주요 기업
    • 시장 동향과 촉진요인
    • 세계 시장 전망

    제3장 시장 분석

    • 미국
    • 캐나다
    • 일본
    • 중국
    • 유럽
    • 프랑스
    • 독일
    • 이탈리아
    • 영국
    • 스페인
    • 러시아
    • 기타 유럽
    • 아시아태평양
    • 호주
    • 인도
    • 한국
    • 기타 아시아태평양
    • 라틴아메리카
    • 아르헨티나
    • 브라질
    • 멕시코
    • 기타 라틴아메리카
    • 중동
    • 이란
    • 이스라엘
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 기타 중동
    • 아프리카

    제4장 경쟁

    LSH 24.11.01

    Global Venous Stents Market to Reach US$2.1 Billion by 2030

    The global market for Venous Stents estimated at US$1.2 Billion in the year 2023, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2023-2030. Iliac Vein Stent Technology, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Wallstent Technology segment is estimated at 8.5% CAGR over the analysis period.

    The U.S. Market is Estimated at US$319.0 Million While China is Forecast to Grow at 11.2% CAGR

    The Venous Stents market in the U.S. is estimated at US$319.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$474.5 Million by the year 2030 trailing a CAGR of 11.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.5% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

    Global Venous Stents Market - Key Trends & Growth Drivers Explored

    Why Are Venous Stents Gaining Importance in Vascular Disease Management?

    Venous stents have emerged as a crucial tool in the management of chronic venous diseases, offering a minimally invasive solution for patients suffering from venous obstructions, deep vein thrombosis (DVT), and other vascular conditions. But what makes these devices so essential in modern vascular care? Venous stents are small, mesh-like metal tubes inserted into veins to restore proper blood flow and prevent vein collapse or blockage. They are specifically designed to address venous insufficiencies, a condition where veins are unable to effectively return blood from the lower extremities back to the heart, causing symptoms like pain, swelling, and varicose veins. Unlike arterial stents, which are used in arteries that handle high-pressure blood flow, venous stents are optimized for veins with lower blood pressure and different structural characteristics. Their design ensures flexibility and conformity to the vessel wall, making them highly effective for maintaining vein patency and alleviating symptoms associated with venous obstruction.

    The demand for venous stents is driven by the increasing prevalence of chronic venous disorders, which affect millions of people worldwide and can lead to severe complications if left untreated. Traditional treatment options, such as compression therapy and anticoagulant medication, often fall short in managing advanced cases of venous obstruction, making stenting a preferred therapeutic option. Venous stents offer a long-lasting solution by physically opening narrowed or blocked veins, thereby improving blood flow and reducing the risk of complications like leg ulcers and recurrent thrombosis. The adoption of venous stents is particularly prevalent in the treatment of conditions such as post-thrombotic syndrome (PTS) and iliac vein compression syndrome (May-Thurner syndrome), where stenting has been shown to significantly improve patient outcomes and quality of life. As awareness of venous diseases and the benefits of stenting continues to grow, healthcare providers are increasingly opting for venous stents as a first-line intervention for complex venous pathologies.

    How Are Technological Innovations Enhancing the Effectiveness of Venous Stents?

    The venous stents market has witnessed significant technological advancements that have improved the safety, efficacy, and durability of these devices. But what are the key innovations driving these developments? One of the most notable advancements is the development of dedicated venous stent designs that address the unique anatomical and physiological challenges of veins. Traditional stents, initially designed for arterial applications, often struggled to provide optimal outcomes when used in venous settings due to the different biomechanical properties of veins. In response, manufacturers have introduced venous-specific stents with features such as greater flexibility, radial force, and resistance to kinking and compression. These stents are engineered to conform to the venous anatomy, even in tortuous or highly curved vessels, ensuring long-term patency and minimizing the risk of migration or fracture. Additionally, the use of nitinol and cobalt-chromium alloys in stent construction has enhanced their strength and elasticity, making them better suited for large-diameter veins and high-compression areas.

    Another critical innovation is the introduction of drug-eluting venous stents, which are coated with pharmacological agents that prevent excessive tissue growth and reduce the risk of in-stent restenosis. This technology, already successful in arterial stents, has shown promise in venous applications, where the risk of restenosis is a significant concern. Drug-eluting stents release anti-proliferative drugs over time, inhibiting the growth of scar tissue within the stent and maintaining lumen patency. Moreover, advancements in imaging technologies, such as intravascular ultrasound (IVUS) and digital subtraction angiography (DSA), have enhanced the precision of stent placement, allowing for more accurate assessment of vein morphology and ensuring that the stent is optimally positioned. The integration of these technologies has not only improved the safety and efficacy of venous stents but has also expanded their use in more complex cases, such as multi-level venous obstructions and recurrent DVT. As a result, the effectiveness of venous stents in treating a broader range of venous diseases has been significantly enhanced, driving their adoption in clinical practice.

    What Market Trends Are Driving the Adoption of Venous Stents in Vascular Treatment?

    Several emerging market trends are shaping the adoption of venous stents in vascular treatment, reflecting the evolving needs of both patients and healthcare providers. One of the most prominent trends is the increasing focus on minimally invasive procedures. As patients and clinicians prioritize faster recovery times, lower complication rates, and reduced hospital stays, there has been a strong shift towards endovascular treatments for venous diseases. Venous stenting, as a minimally invasive option, offers a less traumatic alternative to traditional open surgery, making it a preferred choice for managing chronic venous insufficiency and venous obstructions. This trend is particularly evident in developed regions, where advanced healthcare infrastructure and high patient awareness levels support the widespread adoption of minimally invasive techniques. The shift towards outpatient procedures has also driven the demand for venous stents, as these devices can often be implanted in a same-day setting, minimizing disruption to patients’ daily lives.

    Another significant trend driving the adoption of venous stents is the growing recognition of chronic venous disorders as a major public health issue. With an aging global population and rising incidence of risk factors such as obesity, sedentary lifestyles, and prolonged immobility, the prevalence of venous diseases is on the rise. This has led to increased awareness among healthcare providers and patients about the importance of early diagnosis and intervention. As a result, there is a growing emphasis on screening and treating venous obstructions before they lead to more severe complications, such as venous ulcers or pulmonary embolism. The adoption of venous stents has been further supported by the publication of clinical guidelines and consensus statements that highlight the role of stenting in managing venous diseases. These guidelines, issued by leading vascular societies, have provided clarity on patient selection, procedural techniques, and post-procedure management, facilitating more widespread and standardized use of venous stents across clinical settings. These trends reflect a broader shift towards more proactive and effective management of venous diseases, positioning venous stents as a cornerstone of modern vascular treatment strategies.

    What Factors Are Driving the Growth of the Global Venous Stents Market?

    The growth in the global venous stents market is driven by several factors, including advancements in stent technology, increasing prevalence of venous disorders, and the rising demand for minimally invasive procedures. One of the primary growth drivers is the expanding use of venous stents in the treatment of complex venous pathologies, such as PTS and iliac vein compression. As awareness of these conditions grows and diagnostic capabilities improve, more patients are being identified as candidates for stenting, leading to increased demand for venous stents. The availability of dedicated venous stents that are specifically designed to address the challenges of venous anatomy has also contributed to market growth, as these devices offer better clinical outcomes compared to traditional stents. The development of next-generation stents with enhanced flexibility, radial strength, and resistance to compression has further expanded the range of patients who can benefit from venous stenting, driving adoption in both primary and recurrent cases of venous obstruction.

    Another key growth driver is the increasing investment in research and development by medical device companies. As competition intensifies, manufacturers are focusing on developing innovative venous stents with improved designs and advanced coatings to address the unmet needs of patients and clinicians. Clinical trials and studies demonstrating the long-term safety and efficacy of these new stents are helping to build confidence among healthcare providers, encouraging more widespread use of these devices in clinical practice. Additionally, the rising burden of chronic venous diseases, particularly in aging populations, is creating a need for more effective treatment options. The prevalence of venous disorders is expected to increase as the global population ages, further fueling demand for venous stents. With supportive reimbursement policies and the growing recognition of the clinical benefits of stenting, the global venous stents market is poised for sustained growth, driven by a dynamic interplay of technological innovation, clinical adoption, and demographic trends.

    Select Competitors (Total 43 Featured) -

    • BARD, A Becton, Dickinson Company
    • Boston Scientific Corporation
    • Cook Medical LLC
    • Gore Medical
    • Jotec GmbH
    • OptiMed Medizinische Instrumente GmbH

    TABLE OF CONTENTS

    I. METHODOLOGY

    II. EXECUTIVE SUMMARY

    • 1. MARKET OVERVIEW
      • Influencer Market Insights
      • World Market Trajectories
      • Venous Stents - Global Key Competitors Percentage Market Share in 2024 (E)
      • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • 2. FOCUS ON SELECT PLAYERS
    • 3. MARKET TRENDS & DRIVERS
      • Rising Prevalence of Chronic Venous Insufficiency and Deep Vein Thrombosis Drives Demand for Venous Stents
      • Increased Adoption of Minimally Invasive Vascular Procedures Expands Addressable Market for Venous Stents
      • Surge in Demand for Venous Stents in Post-Thrombotic Syndrome Treatment Fuels Market Growth
      • Rising Adoption of Venous Stents in Outpatient and Ambulatory Surgical Centers Sets the Stage for Market Growth
      • Surge in Use of Venous Stents for Treating Pelvic and Iliac Vein Compression Expands Market Opportunities
      • Technological Innovations in Drug-Eluting and Bioabsorbable Venous Stents Propel Market Growth
      • Rising Utilization of Venous Stents in Cancer and Post-Surgical Complications Fuels Market Demand
      • Surge in Adoption of Venous Stents in Pediatric and Geriatric Venous Disorders Expands Market Opportunities
      • Technological Advancements in Imaging and Navigation Systems for Venous Stenting Propel Market Growth
    • 4. GLOBAL MARKET PERSPECTIVE
      • TABLE 1: World Venous Stents Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
      • TABLE 2: World Recent Past, Current & Future Analysis for Venous Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 3: World Historic Review for Venous Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 4: World 16-Year Perspective for Venous Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
      • TABLE 5: World Recent Past, Current & Future Analysis for Iliac Vein Stent Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 6: World Historic Review for Iliac Vein Stent Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 7: World 16-Year Perspective for Iliac Vein Stent Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 8: World Recent Past, Current & Future Analysis for Wallstent Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 9: World Historic Review for Wallstent Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 10: World 16-Year Perspective for Wallstent Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 11: World Recent Past, Current & Future Analysis for Leg by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 12: World Historic Review for Leg by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 13: World 16-Year Perspective for Leg by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 14: World Recent Past, Current & Future Analysis for Chest by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 15: World Historic Review for Chest by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 16: World 16-Year Perspective for Chest by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 17: World Recent Past, Current & Future Analysis for Abdomen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 18: World Historic Review for Abdomen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 19: World 16-Year Perspective for Abdomen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 20: World Recent Past, Current & Future Analysis for Arm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 21: World Historic Review for Arm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 22: World 16-Year Perspective for Arm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 23: World Recent Past, Current & Future Analysis for Chronic Deep Vein Thrombosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 24: World Historic Review for Chronic Deep Vein Thrombosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 25: World 16-Year Perspective for Chronic Deep Vein Thrombosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 26: World Recent Past, Current & Future Analysis for Post Thrombotic Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 27: World Historic Review for Post Thrombotic Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 28: World 16-Year Perspective for Post Thrombotic Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 29: World Recent Past, Current & Future Analysis for May-Thurner Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 30: World Historic Review for May-Thurner Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 31: World 16-Year Perspective for May-Thurner Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 32: World Recent Past, Current & Future Analysis for Hemodialysis/Arteriovenous Fistulae by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 33: World Historic Review for Hemodialysis/Arteriovenous Fistulae by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 34: World 16-Year Perspective for Hemodialysis/Arteriovenous Fistulae by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
      • TABLE 35: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 36: World Historic Review for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 37: World 16-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

    III. MARKET ANALYSIS

    • UNITED STATES
      • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
      • TABLE 38: USA Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 39: USA Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 40: USA 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 41: USA Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 42: USA Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 43: USA 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 44: USA Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 45: USA Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 46: USA 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • CANADA
      • TABLE 47: Canada Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 48: Canada Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 49: Canada 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 50: Canada Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 51: Canada Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 52: Canada 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 53: Canada Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 54: Canada Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 55: Canada 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • JAPAN
      • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
      • TABLE 56: Japan Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 57: Japan Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 58: Japan 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 59: Japan Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 60: Japan Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 61: Japan 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 62: Japan Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 63: Japan Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 64: Japan 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • CHINA
      • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
      • TABLE 65: China Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 66: China Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 67: China 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 68: China Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 69: China Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 70: China 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 71: China Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 72: China Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 73: China 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • EUROPE
      • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
      • TABLE 74: Europe Recent Past, Current & Future Analysis for Venous Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 75: Europe Historic Review for Venous Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 76: Europe 16-Year Perspective for Venous Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
      • TABLE 77: Europe Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 78: Europe Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 79: Europe 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 80: Europe Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 81: Europe Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 82: Europe 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 83: Europe Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 84: Europe Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 85: Europe 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • FRANCE
      • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
      • TABLE 86: France Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 87: France Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 88: France 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 89: France Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 90: France Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 91: France 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 92: France Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 93: France Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 94: France 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • GERMANY
      • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
      • TABLE 95: Germany Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 96: Germany Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 97: Germany 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 98: Germany Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 99: Germany Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 100: Germany 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 101: Germany Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 102: Germany Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 103: Germany 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • ITALY
      • TABLE 104: Italy Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 105: Italy Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 106: Italy 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 107: Italy Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 108: Italy Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 109: Italy 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 110: Italy Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 111: Italy Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 112: Italy 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • UNITED KINGDOM
      • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
      • TABLE 113: UK Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 114: UK Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 115: UK 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 116: UK Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 117: UK Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 118: UK 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 119: UK Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 120: UK Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 121: UK 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • SPAIN
      • TABLE 122: Spain Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 123: Spain Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 124: Spain 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 125: Spain Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 126: Spain Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 127: Spain 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 128: Spain Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 129: Spain Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 130: Spain 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • RUSSIA
      • TABLE 131: Russia Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 132: Russia Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 133: Russia 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 134: Russia Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 135: Russia Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 136: Russia 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 137: Russia Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 138: Russia Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 139: Russia 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • REST OF EUROPE
      • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 141: Rest of Europe Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 142: Rest of Europe 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 144: Rest of Europe Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 145: Rest of Europe 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 147: Rest of Europe Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 148: Rest of Europe 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • ASIA-PACIFIC
      • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
      • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Venous Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 150: Asia-Pacific Historic Review for Venous Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 151: Asia-Pacific 16-Year Perspective for Venous Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
      • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 153: Asia-Pacific Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 154: Asia-Pacific 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 156: Asia-Pacific Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 157: Asia-Pacific 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 159: Asia-Pacific Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 160: Asia-Pacific 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • AUSTRALIA
      • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
      • TABLE 161: Australia Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 162: Australia Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 163: Australia 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 164: Australia Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 165: Australia Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 166: Australia 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 167: Australia Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 168: Australia Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 169: Australia 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • INDIA
      • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
      • TABLE 170: India Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 171: India Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 172: India 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 173: India Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 174: India Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 175: India 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 176: India Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 177: India Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 178: India 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • SOUTH KOREA
      • TABLE 179: South Korea Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 180: South Korea Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 181: South Korea 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 182: South Korea Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 183: South Korea Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 184: South Korea 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 185: South Korea Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 186: South Korea Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 187: South Korea 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • REST OF ASIA-PACIFIC
      • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 189: Rest of Asia-Pacific Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 192: Rest of Asia-Pacific Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 195: Rest of Asia-Pacific Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • LATIN AMERICA
      • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
      • TABLE 197: Latin America Recent Past, Current & Future Analysis for Venous Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 198: Latin America Historic Review for Venous Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 199: Latin America 16-Year Perspective for Venous Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
      • TABLE 200: Latin America Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 201: Latin America Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 202: Latin America 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 203: Latin America Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 204: Latin America Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 205: Latin America 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 206: Latin America Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 207: Latin America Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 208: Latin America 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • ARGENTINA
      • TABLE 209: Argentina Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 210: Argentina Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 211: Argentina 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 212: Argentina Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 213: Argentina Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 214: Argentina 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 215: Argentina Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 216: Argentina Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 217: Argentina 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • BRAZIL
      • TABLE 218: Brazil Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 219: Brazil Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 220: Brazil 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 221: Brazil Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 222: Brazil Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 223: Brazil 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 224: Brazil Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 225: Brazil Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 226: Brazil 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • MEXICO
      • TABLE 227: Mexico Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 228: Mexico Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 229: Mexico 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 230: Mexico Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 231: Mexico Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 232: Mexico 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 233: Mexico Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 234: Mexico Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 235: Mexico 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • REST OF LATIN AMERICA
      • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 237: Rest of Latin America Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 238: Rest of Latin America 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 240: Rest of Latin America Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 241: Rest of Latin America 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 243: Rest of Latin America Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 244: Rest of Latin America 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • MIDDLE EAST
      • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
      • TABLE 245: Middle East Recent Past, Current & Future Analysis for Venous Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
      • TABLE 246: Middle East Historic Review for Venous Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 247: Middle East 16-Year Perspective for Venous Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
      • TABLE 248: Middle East Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 249: Middle East Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 250: Middle East 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 251: Middle East Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 252: Middle East Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 253: Middle East 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 254: Middle East Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 255: Middle East Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 256: Middle East 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • IRAN
      • TABLE 257: Iran Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 258: Iran Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 259: Iran 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 260: Iran Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 261: Iran Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 262: Iran 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 263: Iran Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 264: Iran Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 265: Iran 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • ISRAEL
      • TABLE 266: Israel Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 267: Israel Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 268: Israel 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 269: Israel Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 270: Israel Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 271: Israel 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 272: Israel Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 273: Israel Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 274: Israel 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • SAUDI ARABIA
      • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 276: Saudi Arabia Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 277: Saudi Arabia 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 279: Saudi Arabia Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 280: Saudi Arabia 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 282: Saudi Arabia Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 283: Saudi Arabia 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • UNITED ARAB EMIRATES
      • TABLE 284: UAE Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 285: UAE Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 286: UAE 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 287: UAE Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 288: UAE Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 289: UAE 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 290: UAE Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 291: UAE Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 292: UAE 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • REST OF MIDDLE EAST
      • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 294: Rest of Middle East Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 295: Rest of Middle East 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 297: Rest of Middle East Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 298: Rest of Middle East 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 300: Rest of Middle East Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 301: Rest of Middle East 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030
    • AFRICA
      • Venous Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
      • TABLE 302: Africa Recent Past, Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 303: Africa Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 304: Africa 16-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2014, 2024 & 2030
      • TABLE 305: Africa Recent Past, Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 306: Africa Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 307: Africa 16-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2014, 2024 & 2030
      • TABLE 308: Africa Recent Past, Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
      • TABLE 309: Africa Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
      • TABLE 310: Africa 16-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2014, 2024 & 2030

    IV. COMPETITION

    • 비교리스트
    0 건의 상품을 선택 중
    상품 비교하기
    전체삭제